Fentanyl Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends | Pfizer Inc., Johnson & Johnson, Sinopharm Group, Merck & Co. Inc., Bayer AG, Novartis AG, Kyowa Kirin Co. Ltd.

Fentanyl Market Size, Share, Trends, Growth Forecast 2024-2033

Overview and Scope
Fentanyl refers to a synthetic opioid that is highly potent and used for pain relief and anesthesia purposes. It is used by doctors to alleviate extreme pain, particularly after surgery and in advanced-stage cancer. It is offered as transdermal patches or lozenges.

Sizing and Forecast
The fentanyl market size has grown strongly in recent years. It will grow from $15.14 billion in 2023 to $16.22 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%.  The  growth in the historic period can be attributed to pain management needs, medical procedures and surgeries, cancer pain management, opioid analgesic market growth, aging population.

The fentanyl market size is expected to see strong growth in the next few years. It will grow to $20.79 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%.  The growth in the forecast period can be attributed to rise in chronic pain cases, expanding oncology therapies, increasing surgical procedures, public health initiatives, regulatory approval for new indications. Major trends in the forecast period include technological advancements in drug formulations, technological innovations in detection, public health and harm reduction strategies, rise in pharmaceutical applications, international collaboration and information sharing.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

Segmentation & Regional Insights
The fentanyl market covered in this report is segmented –
1) By Type:
Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)
2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain
3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users

North America was the largest region in the fentanyl market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of chronic diseases is expected to propel the growth of the fentanyl market going forward. A chronic disease is a medical condition that persists over a long period, typically for three months or more, and often continues throughout a person’s life. Fentanyl is used in chronic diseases primarily to manage severe, persistent pain that other medications or interventions do not effectively control. For instance, in September 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, each year, there are 41 million deaths globally caused by non-communicable diseases (NCDs), which accounts for 74% of all deaths worldwide. Further, in August 2023, according to the data published by the British Heart Foundation, a UK-based non-profit organization, the number of deaths caused by coronary heart disease in the UK increased to 65,579 in 2021, compared with 64,170 in 2020. Therefore, the increasing prevalence of chronic diseases is driving the growth of the fentanyl market.

Key Industry Players
Major companies operating in the fentanyl market report are Pfizer Inc., Johnson & Johnson, Sinopharm Group, Merck & Co. Inc., Bayer AG, Novartis AG, Kyowa Kirin Co. Ltd., Fresenius Kabi Oncology Ltd., Abbott Laboratories, Sanofi S.A, Boehringer Ingelheim GmbH, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, AstraZeneca plc, Apotex Inc., Hisamitsu Pharmaceutical Co. Inc., Alvogen, Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Insys Therapeutics Inc., Exela Pharma Sciences LLC, Paladin Labs Inc., Bryant Ranch Prepack Inc., Galena Biopharma Inc., Validus Pharmaceuticals LLC, Quality Care Products LLC, Dispensing Solutions Inc.

The fentanyl market report table of contents includes:
1. Executive Summary
2. Fentanyl Market Characteristics
3. Fentanyl Market Trends And Strategies
4. Fentanyl Market – Macro Economic Scenario
5. Global Fentanyl Market Size and Growth
…………….
32. Global Fentanyl Market Competitive Benchmarking
33. Global Fentanyl Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Fentanyl Market
35. Fentanyl Market Future Outlook and Potential Analysis
36. Appendix

Explore the trending research reports from TBRC:

https://topprnews.com/vascular-closure-devices-market-outlook/
https://topprnews.com/tourism-event-market-forecast/
https://topprnews.com/global-voice-and-speech-analytics-market-growth/
https://goodprnews.com/small-hydropower-market-growth/
https://goodprnews.com/tourism-event-market-forecast/
https://goodprnews.com/voice-and-speech-analytics-market-forecast/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn:
https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model